Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Growth

    Back to All Ratios
LYKA LABS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.46-15.17-80.40385.973,765.48

What is the latest Core EBITDA Growth ratio of LYKA LABS ?

The latest Core EBITDA Growth ratio of LYKA LABS is 17.46 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.46
Mar2024-15.17
Mar2023-80.40
Mar2022385.97
Mar20213,765.48

How is Core EBITDA Growth of LYKA LABS Trending?

Years Core EBITDA Growth % Change
Mar2025 17.46
Positive
Mar2024 -15.17
Negative
Mar2023 -80.4
Negative
Mar2022 385.97
-89.75
Mar2021 3765.48 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Growth ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹209.6 Cr -2.2% 14.5% -44.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,859.0 Cr 4.2% 5.3% 1.1% Stock Analytics
DIVIS LABORATORIES ₹176,618.0 Cr 3.4% 12.6% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,718.0 Cr 2.2% 4.1% 28% Stock Analytics
CIPLA ₹107,722.0 Cr 2% 11.5% -13.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,081.0 Cr -6.2% 5.1% 9.5% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-2.2%

14.5%

-44.5%

SENSEX

-0.4%

7.1%

-4%


You may also like the below Video Courses